Member Info for sharesaplenty

Whilst placing is not the ideal outcome for the fund raise, don't forget the other option would be to take on a bank loan or other repayable finance. Don't forget a fund raise was needed.
The borrowing path would have diluted the future company profit due to the repayments and any interest charged. This placing route cuts out this dilution of our profits. The other people going to hurt now are short term holders and traders. I'm invested for a minimum of 2-3 years, I want to see the growth story unfold here. So I'm actually really pleased the finance is now in place and we can focus on growing a great company.

you got my gist - thanks. Why would a big pharma sign up to partnership deal with TRX if the financial rug is going to be pull from under the business? I simply don't see this agreement would have happened without that step in diligence being applied. Agreed, economic times are tough at the moment. But actually money is being pumped into banks via governments stimulus packages to support businesses during this Covid19 emergency, so financial deals can be struck and money is available.

Sorry typo, I meant I see a favourable deal will be struck!

Cminhinnett, its all about risk and reward.
Sure wait until the finance package is RNS'ed (which could be anytime) but be prepared to pay significantly more the on current SP. Give the last RNS announcing forward looking tie up with a big pharma partner, I can't see a favourable financial deal being struck here. As normal though, do your own research before investing.

Also backward looking this company has shown year on year growth in revenue, with demand of their products outstripping their ability to supply. What I love is the sales revenue this company is making today, you don't see this in all biotech firms. With revenue for year ending 2018 virtually equalling the MCAP of today. This is going to get a multibag rerate once the COVID19 investor money has exhausted the temporary opportunity available today with pharma firms addressing this short term need. Who's going to need pharma companies supplying wonderful antibody or point of care tests once herd immunity is high enough or we get widescale vaccination, one of which will be coming within months (max a couple of years).
TRX products are going to endure and be in demand for years, no decades, to come.

This is crazy value, if this drops back below a penny I'm topping up despite my big holding already here. Once the full picture emerges here on the finance deal and big pharma partner we'll be nowhere near the penny mark. Worth any potential punters taking a 2nd read of the last RNS, good times are coming.

Just circling back on the coal powered Lemur asset of BMN for a moment. I notice this article in the FT today: https://www.ft.com/content/ca33f62e-242a-4304-9895-f7cea36a497e
Medium to longer term disposing of Lemur is going to make BMN qualifiable for more investors, particularly those of an increasingly green persuasion. Something I think LTHs here will want to see.

Good stuff Chester. Maybe blind faith but I'm with you as in recent months I've been accumulating and hold 1.2 million TRX tickets myself.
Patience to watch TRX now its gonna fly, I'm just lucky to be averaging in <1p. There's too much upside against the downside on balance here. Looking forward to the annual report next month, maybe some more insight on the great progress the company is making

Pdub, sending you big hugs for you and all your family - I'm truly sorry.
Thank you for all your work and time you've invested in BMN research you're contribution has been amazing. Wishing you all the best for the future and spend time doing things now that make you happy, whether or not that is still posting on here.

There is still risk on TRX getting the right financial deal over the line, but after yesterday's RNS this risk seems to be significantly lowered. I can't see TRX now getting a favourable refinancing package. Devil will be in the detail on this, so I hope they include the Ts and Cs when this RNS does land.
I can easily see this being a multibag for 2020 and a great med/long hold. What I love with this company is not just great technology (plenty of other great tech companies out there), but a pipeline for product sales generating cash revenue.

For me this RNS this morning is even bigger for TRX than the re-financing RNS many investors are hoping for. This should build investor confidence of an effective pipeline for their products into the healthcare market having a big player enable this growth. A financing deal coming with a much hoped for RNS merely keeps the wolf from the door, whereas this RNS gives TRX the opportunity to tell the wolf to get lost!

Knuttie, I'm from planet Earth thanks for asking ;-)
If you're wondering why I'm starting to block folk, its to keep my mental health tip top particular during lockdown. Wording like 'idiot' or 'rotten' directed at other board contributors fall into trolling/bullying territory for me - its simply unacceptable and unnecessary as far as I'm concerned. I don't need to read this malice attacking people, so these contributors are added on my filtered list. I will continue to read and research BMN on this page and see what exciting progress is forthcoming with the company. Keep safe everyone.

I've grown intolerant of anyone now directing personal insult against anyone else, positive, negative or anything else regarding interests in BMN. So Sanchez and DaddyBucks your added to my growing list of green coffins, there is simply no need for this nasty conduct . Take your abusive attacks on individuals elsewhere, I'm filtering these trolls and blocking them in any further BMN posts I can see here - bye.
Meanwhile RichKen demonstrates and proves you can provide a responsible rebut and rejection to a comment you might disagree with - thank you RK.

Yes much more pleasant today. Jagadish my action is not to respond and filter out the bullies we've had on here in recent times. Hopefully the polarised trolling of unilateral ramping and deramping contributors who take pleasure in abusing others who have a different view point get the message and sling their hook.
Great discussion this morning on all things BMN.

If you can afford to buy in at this SP you'll do exceedingly well IMO. So much upside here and very little downside risk

Whether my opinion is nonsense or if indeed your's is nonsense is purely subjective.
It depends entirely on the stringency by which investment decisions are made (i.e. not you or I) based on their own research on a company's carbon footprint profile and impact. My point is that Lemur is a coal fired power plant which is as dirty in CO2 footprint in forming energy as you can get. The level of investor diligence applied will increase when we shift from AIM -> main market and the level of investor stringency (private and institutional) applied on a company's carbon footprint profile is only going to increase also, not just to BMN but all company's.
Thanks for clarifying the difference in sum of parts and sale value.

Faramog if Lemur doesn't even figure in the sum of parts valuation then lets get shot of it now as it should have little consequence to the company's balance sheet -even if it were to be gifted away. Its an unnecessary distraction on the vanadium resource priority and the vertical integrated supply for the business.
Dispatching of Lemur would allow us to be geared up in readiness for entry into the FTSE main market, which we are told is coming. At which point green fund managers will conduct due diligence on BMN, at which point our holding of Lemur will act to dissuade investment that might otherwise be incoming. Even on our AIM listing, I suspect its still happening albeit to a lesser extent.

Roger that ;-)
Imagine how much more attractive BMN would be once it divested off Lemur. Some green ethical fund managers will be lined up ready to pull the trigger to invest into BMN once all the fossil feedstock assets are gone.

Thanks Pdub for the clarification, I'm not too familiar with the various market facing VRFB entities operating in different jurisdiction and geographies. so apologies for my ignorance here. If the UK market is being led by Invinity, then this is where the better engagement of VRFB needs to be driven and not BMN/BE per se. As BMN holders I'd like to see how can help encourage Invinity (if indeed we can) access the Innovate UK and other UK gov/public funding that is and will be to a greater degree put on the table here.
The vertical mining VRFB offering of BMN can then share in the value formed here.

Lets hope the Invinity and Enerox activities are the springboard Mikeetg for widescale adoption of VRFBs. When the drive of BMN shifts from the cost basis to supply commodity vanadium towards the value created with VRFB this is when we'll get rocket fuel injected into the BMN share price. Until then patience is the game.